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A B S T R A C T
Vascular remodeling in hypertension and diabetes is characterized by a low-grade inflammation of the arterial
wall and enhanced oxidative stress. Wine pomace products attenuate hyperglycemia and hypertension through
reduction of oxidative stress and inflammation by their polyphenol composition. The aim of the study was to
assess the influence of the wine pomace product (WP) on morphometric parameters of the arterial wall in
spontaneously hypertensive rats (SHRs) and streptozotocin-diabetic rats (STZ). Oxidative stress was also eval-
uated by determination of radical oxygen species (ROS) and endothelial nitric oxide synthase (eNOS) activation
in thoracic aortas. Wine pomace reduces wall aortic thickness, cross sectional area and wall/lumen ratio, and
decreases ROS and increases eNOS activation. In summary, the supplementation of hypertensive or diabetic rats
with the wine pomace product exhibits a protective role against the endothelial dysfunction and vascular re-
modeling.
1. Introduction
Endothelial cells, smooth muscle cells and fibroblasts interact in a
functional complex to form the vascular wall. Changes in the environ-
ment sensed by the vascular wall produce several intracellular signals
and mediators that regulate vascular structure and function. This pro-
cess is known as vascular remodeling and involves changes in the cell
growth and death, cell motility and composition of the extracellular
matrix (Renna, De Las Heras, & Miatello, 2013).
Vascular remodeling is an active process that response to physio-
logical and pathological changes in the hemodynamics conditions as
consequence of different stimuli like hypertension, hyperglycemia and
other inflammatory diseases (Van Varik et al., 2012). Several in-
tracellular systems and mediators intervene in the vascular remodeling
associated to hypertension and hyperglycemia. They include pro-in-
flammatory and pro-oxidant agents such as angiotensin II (Ang II). Ang
II mediates reactive oxygen species (ROS) generation by NADPH oxi-
dase, intracellular signaling activation such as MAPK, PI3K and NF-κB
pathways and the consequent gene regulation (Renna et al., 2013).
Oxidative stress is related to the development of vascular re-
modeling and endothelial dysfunction. The oxidative stress activates
redox-sensitive inflammatory molecules such as AP-1 and NF-kB, which
amplify the inflammatory response by cytokines, chemokines, and
lymphokines to ultimately induce more vascular inflammation (Renna
et al., 2013). Thus, antioxidant treatment could ameliorate vascular
alterations associates to pro-inflammatory pathologies such as hy-
pertension and diabetes.
Food polyphenols have demonstrated antioxidant, anti-in-
flammatory and anti-cancer properties, blood pressure, lipid and glu-
cose modulation, and gene expression regulation. By acting through
different mechanisms, polyphenols prevent and reverse oxidative stress
associated to chronic diseases (Zhang, Qi, Liu, Zhang, & He, 2015; Del
Pino-García, Rivero-Pérez, González-SanJosé, Croft, & Muñiz, 2017;
Gerardi, Cavia-Saiz, Rivero-Pérez, González-SanJosé, & Muñiz, 2019).
Phenolic compounds such as ferulic, resveratrol, catechin, epigalloca-
techin and quercetin reduce oxidative stress and their related vascular
disorders by modulation of different cellular mechanisms. In this sense,
they can act by direct ROS neutralization and/or through increasing the
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endogen antioxidant systems. They can also regulate the ROS/nitric
oxide (NO) balance by reducing ROS production through the NADPH
oxidases, and by increasing NO bioavailability. Moreover, polyphenols
modulate several signaling pathways including the activation of anti-
oxidant pathways (Akt, Nrf2, SIRT1), the inhibition of pro-oxidant and
pro-inflammatory signaling (NF-κB), and the promotion of the gene
expression of antioxidant and anti-inflammatory proteins such as en-
dothelial nitric oxide synthase (eNOS), superoxide dismutases (SOD)
and heme oxygenase-1 (HO-1).
In previous studies the supplementation of rats with a wine pomace
product rich in polyphenols attenuates oxidative stress associated to
hypertension and type 1 diabetes (Del Pino-García, Rivero-Pérez, et al.,
2016; Del Pino-García et al., 2017). Both blood pressure and glucose
was reduced by the wine pomace (WP) and oxidative damage was
lowered. In the present study, the vascular remodeling in aortas of
spontaneously hypertensive rats (SHRs) and streptozotocin-induced
diabetic rats (STZ) was evaluated after administration of wine pomace
(WP) and compared with placebo administration. Oxidative and in-
flammatory parameters were also studied and include ROS generation
and eNOS activation.
2. Material and methods
2.1. Red wine pomace product (WP)
Red wine pomace-derived product from the vinification of Vitis vi-
nifera L. cv. Tempranillo was prepared at the University of Burgos ac-
cording to a previously described method (González-SanJosé, García-
Lomillo, Del Pino-García, Muñiz-Rodríguez, & Rivero-Pérez, 2015).
This product was obtained from seedless red wine pomace (WP) using a
heat treatment as stabilization process, and its main characteristics and
composition (dietary fibre, fat, protein, minerals and phenolic classes)
have been determined previously (Gerardi et al., 2019) and are sum-
marized in Tables S1 and S2, Supplementary material.
2.2. Animals
Experimentation with live animals was approved by the Ethics
Committee for Experimental Animal Care at the University Hospital of
Burgos and was carried out in accordance with the Spanish and
European laws (Royal Decree 53/2013 of the Spanish Ministry of
agriculture, Food and Environment and Ministry of Economy and
Competitiveness, and European Directive 2010/63/EU). Adult male
Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHRs)
weighing 307 ± 13 g were assigned to 6 groups (n = 5 rats/group).
The room was maintained at 21 ± 2 °C and humidity at 40 ± 10%,
with a 12:12-h light:dark cycle and free access to food (A04, Panlab,
S.L.U., Barcelona, Spain) and water.
2.3. Experimental animal groups and general procedures
Animals were divided into 6 groups (n = 5 rats/group): control (C),
control supplemented (C + WP), hypertensive (SHR), hypertensive
supplemented (SHR + WP), diabetic (DB) and diabetic supplemented
(DB + WP). Spontaneously hypertensive rats (SHRs) were used in the
SHR groups. Hypertension was confirmed from the beginning of the
experiment by blood systolic pressure measurements ˃ 200 mmHg.
Diabetes was induced in overnight fasted rats of DB groups by a single
intraperitoneal injection of 45 mg/kg of streptozotocin (STZ, Sigma-
Aldrich, St Louis, MO, USA) dissolved in 0.1 M citrate buffer (pH 4.6).
The diabetic was confirmed 3 days later by blood glucose levels ˃
350 mg/dl. Rats in the supplemented groups received the WP (300 mg/
kg/d) dissolved in water by oral gavage. The dosage evaluated in the
present work was selected by the authors according to previous studies
(Del Pino-García et al., 2017; Gerardi, Cavia-Saiz, Rivero-Perez,
González-SanJosé, & Muñiz, 2020). The human equivalent dose (HED)
was also considered due to the potential use of the WPP as dietary
supplement. The 300 mg/kg/d dose was equivalent in human to 3 g/d.
The study was finished after 4 weeks of supplementation. The last
day of study, a combined ketamine/xylazine anesthetic (80 mg keta-
mine/kg and 20 mg xylazine/kg) was administrated to rats by in-
traperitoneal injection. Then, rats were euthanized by intra-cardiac
injection of Sodium Pentobarbital (300 mg/kg). Thoracic and abdom-
inal aortic tissues from each rat was collected and frozen at −80 °C or
fixed in 4% paraformaldehyde.
2.4. Aortic morphometric analysis
Fixed aortic tissue was sectioned and stained with hematoxylin and
eosin for the analysis of the morphological changes. Aortic wall thick-
ness and the internal diameter were measurement by a Nikon Eclipse
LV100NPOL microscope with a High-precision rotating stage and using
the NIS Element Software. The wall-to-lumen (W/L) ratio was eval-
uated by the ratio of wall thickness to the internal diameter of lumen.
The cross sectional area (CSA) of the aorta was calculated as CSA = π
(Re2 – Ri2) where Re and Ri are the external and internal radii, re-
spectively.
2.5. Reactive oxygen species (ROS) detection
For the analysis of ROS in the aortic tissue, frozen aortas were
embedded in freezing medium and transverse sections were obtained
with a cryostat, collected on glass slides and equilibrated in phosphate
buffer (pH 7.4). Slides were incubated for 30 min at 37 °C with 2,7-
dichlorodihydrofluorescin diacetate (DCFH-DA, Sigma-Aldrich, St
Louis, MO, USA) solution (10 µM in DMSO) in a light-protected hu-
midified chamber. Images were obtained with a Leica CTR6000 mi-
croscope. The fluorescence images were quantified using ImageJ
Software and results are expressed as percentage to the control.
2.6. Western blotting analysis
The aortic tissue was homogenized in ice-cold lysis buffer for the
extraction of total proteins. Protein concentration was measured using a
protein assay reagent (Quick Start™ Bradford Protein Assay, Bio-Rad,
Hercules, CA, USA). Total protein (40 µg) was treated with Laemmli
buffer, boiled for 5 min and resolved by 10% SDS-PAGE (Bio-Rad Mini-
Protean Tetra cell). Then, protein were electrophoretically transferred
(Bio-Rad Trans-Blot Turbo Blotting System) into a PVDF membranes
(Bio-Rad Laboratories, Hercules, CA, USA) and incubated overnight at
4 °C with specific primary rabbit antibodies (1:1000) against phospho-
eNOS and actin (Sigma-Aldrich). After rinsing, the membranes were
incubated with a horseradish-peroxidase-labeled secondary antibody
anti-rabbit (1:3000, Anti-rabbit IgG-HRP-linked Antibody, Cell
Signaling Technology, Danvers, MA, USA). Inmunodetection was per-
formed using enhanced chemiluminescence kit (Clarity Western ECL
substrate, Biorad Laboratories, Hercules, CA, USA) and developed using
autoradiography (Amersham Hyperfilm ECL, GE Heaalthcare). Proteins
bands were quantified by densitometry using the ImageJ software and
their relative amounts were normalized to the housekeeping protein β-
actin. The results were expressed as a ratio of the phosphorylated target
protein amount against the total β-actin protein.
2.7. Data presentation and statistical analysis
The results were expressed as means ± standard deviation of in-
dependent samples (n = 5). Statistical analysis was performed using
Statgraphics® Centurion XVI, version 16.2.04 (Statpoint Technologies,
Inc., Warranton, VA, USA). One-way analysis of variance (ANOVA),
using Fisher's least significant difference (LSD) test, was used to de-
termine significant differences between the different experimental
groups. A value of p < 0.05 was applied to all analyses.
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3. Results
3.1. Histological analysis of aortic structure
To investigate the effect of the wine pomace product (WP) in the
hypertensive and diabetic vasculopathy, vascular wall thickness, cross
sectional area (CSA) and wall/lumen (W/L) ratios were evaluated in
thoracic and abdominal aortas of SHRs (hypertensive rats: SHR), STZ
(diabetic rats: DB) and WKY (normal control rats: C) rats. Thoracic
aortas were analyzed in sections stained with hematoxylin and eosin
(Figs. 1 and 2).
Fig. 1 shows morphological appearance of the thoracic (A) and
abdominal (B) aortic wall in normal rats (C), hypertensive rats (SHR)
and diabetic rats (DB) treated (WP) or untreated (Placebo) with the
wine pomace product. The values of wall thickness in all groups are
shown in the graphs below the aortic wall images. Wall thickness of
SHR and DB rats were significantly higher than that in control rats for
both thoracic and abdominal aortas (Fig. 1). WP supplemented rats
exhibited significant decreases in both aortic wall thicknesses when
compared with the placebo group. The reduction of the wall thickness
was about 16% (thoracic aortas) and 14% (abdominal aortas) for the
SHR rats and 31% (thoracic aortas) and 8% (abdominal aortas) for DB
rats comparing the supplemented rats with the correspondent placebo
group.
Fig. 2 illustrated the thoracic (A) and abdominal (B) aortic structure
in all groups treated (WP) or untreated (Placebo) with the wine pomace
product. Cross sectional area (CSA) of aortas and wall/lumen (W/L)
ratio are showed in the graphs below. A hypertrophy of thoracic and
abdominal aortas was observed in SHR rats, as showed the 40% and
25% increment observed in the CSA, comparing with control group. WP
reduced this CSA by 16% and 14% compared with the placebo SHR rats.
Diabetic rats only experimented an elevation in the CSA of the ab-
dominal aortas but not the thoracic. The ingestion of the WP reduced
the CSA of DB rats by 16% and 10% for the thoracic and abdominal
aortas, respectively. The W/L ratio of both section of aortas of the SHR
rats were significantly greater than that of the control group, while no
significant differences were observed between control and DB groups
(Fig. 2). WP administration to SHR rats reduced the W/L ratio by 18%
and 26% for the thoracic and abdominal aortas, respectively. In addi-
tion, the W/L ratio of the thoracic aorta was reduced by 17% for the
WP-treated DB rats.
3.2. Oxidative stress in the thoracic aorta
Radical oxygen species (ROS) production in thoracic aortas were
evaluated by DAF-2 fluorescence and it is illustrated in Fig. 3. ROS
generation was increased in SHR rats when compared with the control
group. No significant differences were observed between DB and con-
trol rats. In addition, WP intake alleviated ROS in SHR rats and also
reduced ROS production in DB and control groups compared with the
Fig. 1. Effect of wine pomace product (WP) supplementation on the rat aortic wall thickness. Morphological appearance of the thoracic (A) and abdominal (B)
aortic wall was study by haematoxylin and eosin staining of the aortic slices. Wall thickness was measured and results are showed in the graphs below the images.
Significant differences (n = 5, ANOVA, p < 0.05) between control, hypertensive and diabetic rats are represented with Latin Letters for placebo groups and Greek
Letters for supplemented group. Significant differences (n = 5, Student‘s t-test, p < 0.05) between placebo and WP for each group are represented with an asterisk
(*). C: control rats; SHR: hypertensive rats; DB: diabetic rats; Placebo: rats not supplemented with the wine pomace product; WP: rats supplemented with 300 mg/kg/
d of wine pomace product.
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placebo.
3.3. Nitric oxide in thoracic aorta
Western blot analysis was conducted to measure the protein ex-
pression levels of endothelial nitric oxide synthase (eNOS) in thoracic
aortic tissue (Fig. 4). The protein phosphorylation of eNOS was sig-
nificantly decreased in the SHR rats compared with the control group.
The WP intake increased the eNOS phosphorylated levels of the SHR
rats in about 2.3 fold times. No significant differences were observed
between DB and control rats in the eNOS levels.
4. Discussion
The results show that the administration of wine pomace product
(WP) modified some cardiovascular alterations associated to
hypertension and type 1 diabetes mellitus in two independent rat
models. We previously reported that the administration of this WP
ameliorates vascular complications of diabetes and hypertension by
alleviating hyperglycemia, hipoinsulinemia, hypertension and their
associated vascular oxidative damage (Del Pino-García, Rivero-Pérez,
et al., 2016; Del Pino-García et al., 2017). Here we report the effect of
the WP, rich in polyphenols, in the vascular structure and its association
with the vascular oxidative status.
It has been demonstrated that the polyphenols of the WP suffer both
enzymatic digestion and microbial metabolization in the gastro-
intestinal tract leading to several types of metabolites that can be ab-
sorbed and exert their antioxidant effects in different cells and tissues
(Del Pino-García et al., 2016; Gerardi et al., 2019; Gerardi et al., 2020).
However, some phenolic compounds of the WP have polymeric struc-
tures and they are poorly absorbed, exerting their actions by local
modulation of the intestinal barrier and microbiota. In this sense, the
Fig. 2. Effect of wine pomace product (WP) supplementation on the rat aortic cross sectional area (CSA) and wall/lumen ratio.Morphological appearance of
the thoracic (A) and abdominal (B) aorta was study by haematoxylin and eosin staining of the aortic slices. Cross sectional (CSA) area and wall/lumen ration were
measured and results are showed in the graphs below the images. Significant differences (n = 5, ANOVA, p < 0.05) between control, hypertensive and diabetic rats
are represented with Latin Letters for placebo groups and Greek Letters for supplemented group. Significant differences (n = 5, Student‘s t-test, p < 0.05) between
placebo and WP for each group are represented with an asterisk (*). C: control rats; SHR: hypertensive rats; DB: diabetic rats; Placebo: rats not supplemented with the
wine pomace product; WP: rats supplemented with 300 mg/kg/d of wine pomace product.
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WP has high amounts of dimeric procyanthocyanidins, principally
procyanidin B2. Some authors showed that dimeric, oligomeric and
high weight proanthocyanidins improve the lipid profile of dyslipi-
demic individuals (Pal, Naissides, & Mamo, 2004: Wong et al., 2016)
and reduce the markers of oxidative stress and inflammation in in-
dividuals with metabolic syndrome and diabetes (Cani, Osto, Geurts, &
Everard, 2012; Wong et al., 2016).
Cardiovascular risk factors such as hypertension and diabetes alter
the redox state in the vessel and can led in endothelial dysfunction
affecting vascular structure and function (Khoo et al., 2010). This
vascular alteration is associated to oxidative stress and linked to an
imbalance between nitric oxide (NO) and radical oxygen species (ROS)
generation in the endothelial cells. Thus, the inhibition of oxidative
stress becomes an important aspect to consider in explaining the ben-
efits of the WP-polyphenols in the endothelial dysfunction.
The vascular system is exposed to alterations such as hypertension
and hyperglycemia that induce arterial remodeling. In this process
smooth muscle cells (SMCs) increase their proliferation which results in
medial thickening of arteries and arterioles (Xu et al., 2001). Arterial
remodeling is characterized by a low-grade inflammation of the arterial
wall with inflammatory cell infiltration, enhanced oxidative stress and
upregulation of inflammatory mediators including endothelial adhesion
molecules (VCAM-1, ICAM-1), pro-inflammatory transcriptional factor
NF-κB and other proinflammatory molecules (MCP-1, PAI-1). Arterial
remodeling can be either hypertrophic (thickening of the vascular wall
and increased cross sectional area), eutrophic (constant wall thickness)
or hipotrophic (reduced cross sectional area), and can be outward (in-
creased lumen diameter) or inward (reduced lumen diameter) (Renna
et al., 2013). Although eutrophic remodeling has been described in
primary hypertension in humans and in small arteries of SHRs rats;
hypertrophic is found in secondary hypertension such as hypertension
associated to diabetes mellitus, in hyperaldoresteronism, or in pheo-
chromocytoma (Schiffrin, 2012; Van Varik et al., 2012). Large central
arteries such as aorta undergo arteriosclerotic changes with outward
hypertrophic remodeling characterized by increased cross sectional
area (CSA) and lumen diameter (O’Rourke & Hashimoto, 2007). These
changes were observed in the abdominal and thoracic aortas of the
hypertensive rats evidencing the presence of hypertrophic changes with
Fig. 3. Analysis of oxidative stress in rat thoracic
aortic tissue. Dichlorodihydrofluorescein staining
shows radical oxygen species (ROS) generation in
thoracic (A) and abdominal (B) aorta. Fluorescence
was quantified and results expressed as percentage
of increase in relation to control, and they are
showed in the graph below the images Significant
differences (n = 5, ANOVA, p < 0.05) between
control, hypertensive and diabetic rats are re-
presented with Latin Letters for placebo groups and
Greek Letters for supplemented group. Significant
differences (n = 5, Student‘s t-test, p < 0.05) be-
tween placebo and WP for each group are re-
presented with an asterisk (*). C: control rats; SHR:
hypertensive rats; DB: diabetic rats; Placebo: rats not
supplemented with the wine pomace product; WP:
rats supplemented with 300 mg/kg/d of wine po-
mace product.
Fig. 4. Expression levels of endothelial nitric oxide synthase (eNOS) in a
thoracic aorta by western blotting. Proteins from thoracic aortas were in-
solated and eNOS phosphorylation was analyzed by western blot. Results re-
presented in the graph are expressed as the ratio of the phosphorylated eNOS
amount against the total β-actin protein. Significant differences (n = 5,
ANOVA, p < 0.05) between groups are represented with Latin Letters. C:
control rats; SHR: hypertensive rats; SHR + WP: hypertensive rats supple-
mented with 300 mg/kg/d of wine pomace product; DB: diabetic rats;
DB + WP: diabetic rats supplemented with 300 mg/kg/d of wine pomace
product.
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an increase in the lumen and wall area of the aortas. The intake of WP
by the hypertensive rats prevents the vascular remodeling by reducing
the aortic CSA and wall thickness observed in the hypertensive rats.
Furthermore, wine pomace ingestion also reduced the wall/lumen
ratio. It was observed that hypertensive patients with the highest wall/
lumen ratio had increased incidence of cardiovascular events. Thus, the
reduction of this alteration by the WP could contribute to a less in-
cidence of cardiovascular complications. Some authors propose that
antihypertensive agents may affect the vascular wall directly by redu-
cing Angiotensin II (Ang II) response, and indirectly by blood pressure
lowering. In previous studies we evidenced antihypertensive action of
the WP with reduction in the blood pressure, thus the WP could have
indirect action in the amelioration of the vascular remodeling. Poly-
phenols of the WP such as flavonoids also reduce the gene expression of
angiotensin converting enzyme (ACE) and this contribute to the low-
ering of the Ang II effects (Balasuriya & Rupasinghe, 2011). By reducing
pro-oxidant and proinflammatory actions of Ang II, NADPH oxidase
activation decreases, with less generation of reactive oxygen species
(ROS), decreased activity of the mitogen activated protein kinases
(MAPK) and consequent reduction of the activation of proto-oncogenes
c-fos, c-jun and c-myc that leads to reduced growth of SMCs and re-
modeling. In addition, the activation of the pro-inflammatory tran-
scriptional factor NF-κB and cell adhesion molecules are reduced after
Ang II inhibition and this diminish the extravasation of leukocytes into
the vascular wall. Furthermore, there is an important role of the per-
oxisome proliferator activator receptor PPAR-γ against the Ang II effect
in the vascular remodeling (Schiffrin, 2012). Since resveratrol and other
polyphenols of the WP exhibit a stimulatory effect in PPAR-γ, this could
improve the Ang II-vascular remodeling (Abraham Domínguez-Avila,
González-Aguilar, Alvarez-Parrilla, & de la Rosa, 2016). In this sense, it
is important to highlight the importance of resveratrol in the prevention
of vascular remodeling as other works demonstrated the effectiveness of
this molecule in the prevention of aorta remodeling in different models
of hypertension such as spontaneously and malignantly hypertensive
rats (Grujic-Milanovic et al., 2017). Altogether, the antioxidant and
anti-inflammatory action of the polyphenols in the WP contribute to
regression of remodeling of the aortas.
Diabetes cause structural changes of large and small arteries and
associated endothelial dysfunction that accelerated the process of ar-
terial remodeling. Diabetes-associated vascular remodeling exhibits
modifications of the extracellular matrix (ECM), dysfunction of en-
dothelial cells (ECs) and SMCs, and changes in the circulating cyto-
kines. These alterations conduce to thickening of the intima and media
of the large vessels, increasing the risk for cardiovascular complications
(Spinetti, Kraenkel, Emanueli, & Madeddu, 2010). Abdominal aortas of
diabetic rats suffer hypertrophic outward remodeling with no changes
in the wall/lumen ratio. The increase in the lumen diameter with the
less thickening of the aortic wall compared with the hyperglycemic
aortas explains the no modification in the wall/lumen ratio for the
diabetic aortas. Additionally, thoracic aortas of diabetic rats showed
similar thickening than the abdominal aortas but conserved cross sec-
tional area and lower wall/lumen ratio. These observations suggest a
different degree of remodeling in the large vessels as consequence of
diabetes type 1 compared with the hypertensive aortas. In all cases, the
treatment with the WP improves the structural of the aorta and reduces
the vascular remodeling. Hyperglycemia also increased Ang II produc-
tion and its related-vascular remodeling is accompanied by NAPDH
oxidase and NF-κB activation. Reduction of Ang II signaling, inhibition
of NF-κB and lowering of ROS production by polyphenols contribute to
the anti-remodeling action of the WP in the diabetic aortas (Del Pino-
García, Gerardi, et al., 2016; Gerardi et al., 2019). No changes were
observed in the aortas of normal rats after WP consumption, indicating
the absence of vascular changes by the WP in normal aortas.
Enhanced ROS production was found in the hypertensive aortas.
Main sources of endothelial ROS production are the NADPH oxidases,
principally the isoforms NOX2 and NOX4. NOX2 is responsible of ROS
production in response to Ang II and other pathological signals,
whereas NOX4 is implicated in basal ROS production. NOX2 is upre-
gulated in cardiovascular diseases such as hypertension and athero-
sclerosis (Fan et al., 2014). Thus, the increased oxidative stress ob-
served in the hypertensive aortas could be associated to increased
NAPDH oxidase activity (Del Pino-García, Gerardi, et al., 2016). Fur-
thermore, Maia et al. (2014) associated this oxidative stress to in-
creased superoxide anion production. This is consistent with previous
works in which the expression of superoxide dismutase 2, the re-
sponsible enzyme that catalyzes dismutation of superoxide, was re-
duced in hypertensive rats (Del Pino-García et al., 2017). Superoxide
anion could react with NO and reduce its bioavailability. Furthermore,
superoxide anion produces the uncoupling of eNOS and this generates
more superoxide increasing the pro-oxidant status. However, the WP
ingestion by the hypertensive rats reduced the aortic ROS levels pos-
sible due the antioxidant effect of the polyphenols. Several mechanism
are involved in the antioxidant activity of the polyphenols in the WP
including superoxide scavenging action and NAPDH oxidase inhibition
by catechin, epicatechin and epigallocatechin, reduced expression of
NF-κB by gallic acid, and stimulation of SOD2 and other antioxidant
enzymes through Akt and Sirt-1 activation by resveratrol and ferulic
acid (Del Pino-García, Gerardi, et al., 2016; Gerardi et al., 2019; Serino
& Salazar, 2019).
Endothelial dysfunction is characterized by a reduced NO produc-
tion in aorta and this is associated with reduced phosphorylation of
endothelial nitric oxide synthase (eNOS) (Maia et al., 2014) as observed
for the hypertensive rats. However, WP significantly increases eNOS
phosphorylation in the SHR. This observation was consistent with a
previous study that showed a increased NO bioavailability in SHRs-
hypertensive rats supplemented with WP (Del Pino-García et al., 2017).
In this sense, WP reduce vascular remodeling by increased NO pro-
duction that inhibit vascular smooth muscle cell proliferation (Spinetti
et al., 2010). In another aspect, previous reports showed that diabetes
mellitus increases peroxynitrite radicals and decreases constitutive ni-
tric oxide production (López-Villodre et al., 2016). Furthermore,
atherosclerosis of the diabetic vessel wall caused eNOS dysfunction in
which eNOS phosphorylation is reduced due decreased Akt activity,
and eNOS also is inactivated by DAG/PKC pathway (Spinetti et al.,
2010). Type 1 diabetes mellitus did not significantly modify vascular
eNOS protein phosphorylation in our experimental model but a slightly
increase was observed for the administration of WP in the DB rats. WP
polyphenols could increase eNOS phosphorylation by stimulation of
kinases such as Akt (Gerardi et al., 2019). Likewise, it was demon-
strated that grape polyphenols enhance eNOS activity and increase NO
production in endothelial cells. Activation and phosphorylation of
eNOS by polyphenols involves an estrogen receptor α-dependent (ERα),
the PI3K-Akt and the MAPK-ERK1/2 pathways (Stangl, Dreger, Stangl,
& Lorenz, 2007). Resveratrol also increase eNOS gene expression by
activating PPARα in endothelial cells (Mokhtar & Rasool, 2017).
An important observation between hypertensive and diabetic vas-
cular changes is the fact that diabetic aortas did not suffer alterations in
their oxidative and nitrosative levels, reflected by the unaltered ROS
levels and eNOS phosphorylation. The absence of these alterations
could explain the less modification in the morphology of the diabetic
aortas compared with the hyperglycemic.
Overall, the administration of WP interfered with the development
of pathological vascular changes in hypertension and type 1 diabetes
mellitus. The WP action include an enhanced antioxidant response
against oxidative stress in aortic tissue that improve vascular function
in diabetic and hypertensive rats and, also comprise the promotion of
NO bioavailability by increasing eNOS phosphorylation and NO pro-
duction in aorta of hypertensive rats. The present study documents that
wine pomace product can reduce the diabetic and hypertensive vas-
culopathy, although additional studies will needed to determine the
potentially effect in humans.
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